Evidence map›Paper›PMID 39698884›Full record

ArticleRecent patents on biotechnology2026

Antimicrobial Effect of Formononetin Against the Periodontal Pathogens

Negar Delfan, Maryam Dalaei Moghadam, Pegah Shakib, Asma Sepahdar, Zahra Naghibeiranvand

Abstract read
PubMed Publisher
In one paragraph

Article in Recent patents on biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Negar DelfanRazi Herbal Medicines Research Center, Student Research Committee, School of Dentistry, Lorestan University of Medical Sciences, Khorramabad, Iran.
Maryam Dalaei MoghadamRazi Herbal Medicines Research Center, Department of Endodontics, School of Dentistry, Lorestan University of Medical Sciences, Khorramabad, Iran.
Pegah ShakibRazi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Asma SepahdarRazi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Zahra NaghibeiranvandSchool of Dentistry, Lorestan University of Medical Sciences, Khorramabad, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAmong the bioactive isoflavones identified from different plants is formononetin. Formononetin's antioxidant, anti-inflammatory, and anti-cancer qualities have all received a lot of attention lately. The goal of the current investigation was to examine formononetin's antifungal and antibacterial activity against

methodsThe present study determined the Minimum Inhibitory Concentration (MIC), Minimum Bactericidal Concentration (MBC), and Minimum Fungicidal Concentration (MFC) of formononetin, chlorhexidine, formononetin + chlorhexidine, Formononetin + nystatin, and nystatin against

resultsChlorhexidine + formononetin and formononetin alone had the greatest and lowest minimum inhibitory concentrations (MIC) against

conclusionThe findings demonstrated a considerably greater antibacterial effect (P<0.05) for the combinations of formononetin + nystatin and chlorhexidine as compared to nystatin and chlorhexidine alone.

Indexed as

Anti-Bacterial AgentsAntifungal AgentsAnti-Infective AgentsCandida albicansEnterococcus faecalisIsoflavonesChlorhexidineHumansMicrobial Sensitivity TestsNystatinAnti-Bacterial AgentsAntifungal AgentsAnti-Infective AgentsChlorhexidineformononetinIsoflavonesNystatinAntimicrobial effectsformononetinminimum bactericidal concentrationminimum fungicidal concentrationminimum inhibitory concentrationnystatin.

Identifiers

PMID39698884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.